Atlas Trials

Quadratic Phenotypic Optimisation Platform (QPOP) Utilisation to Enhance Selection of Patient Therapy Through Patient Derived Organoids in Breast Cancer

Clinical trial NCT05177432 · UNKNOWN

Trial details

NCT number
NCT05177432
Sponsor
National University Hospital, Singapore
Status
UNKNOWN
Phase
Phase 1
Study type
INTERVENTIONAL
Breast Cancer
Start date
2021-12-06
Primary completion
2025-01-03
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.